Why the study?
To analyze the relationship between U.S. workers' reported ADHD symptomatology and the impact of pandemic conditions on symptomatic impairment and estimated Adult ADHD prevalence.
Did the COVID-19 pandemic increase reported ADHD symptomatology and the estimated prevalence of Adult ADHD among U.S. workers?
Population
U.S. workers
Comparison
ASRS screener data collected during the pandemic vs data from two pre-pandemic studies
Key result
During the COVID-19 pandemic, the estimated prevalence of adult ADHD diagnosis among U.S. workers increased to 9.26% compared to a pre-pandemic estimate of 4.4%.
Authors
Loading...
Pandemic linked to higher worker ADHD prevalence; hypothesis-generating and requires longitudinal studies before clinical adoption.
Cross-Sectional (n=921)
Did the COVID-19 pandemic increase reported ADHD symptomatology and the estimated prevalence of Adult ADHD among U.S. workers?
Absolute Event Rate: 9.26% vs 4.4%
The COVID-19 pandemic was associated with a significant increase in self-reported ADHD impairment and estimated prevalence among U.S. workers, highlighting the need to support neurodiverse employees in new work environments.
Edwards et al. (2025) conducted a cross-sectional in Attention-Deficit/Hyperactivity Disorder (ADHD) (n=921). COVID-19 pandemic conditions vs. Pre-pandemic conditions was evaluated on Estimated population prevalence of adult ADHD. During the COVID-19 pandemic, the estimated prevalence of adult ADHD diagnosis among U.S. workers increased to 9.26% compared to a pre-pandemic estimate of 4.4%.